NO976125D0 - Farmasöytisk amiodaronblanding for parenteral levering - Google Patents

Farmasöytisk amiodaronblanding for parenteral levering

Info

Publication number
NO976125D0
NO976125D0 NO976125A NO976125A NO976125D0 NO 976125 D0 NO976125 D0 NO 976125D0 NO 976125 A NO976125 A NO 976125A NO 976125 A NO976125 A NO 976125A NO 976125 D0 NO976125 D0 NO 976125D0
Authority
NO
Norway
Prior art keywords
pct
amiodarone
pharmaceutical
mixture
parenteral delivery
Prior art date
Application number
NO976125A
Other languages
English (en)
Other versions
NO317061B1 (no
NO976125L (no
Inventor
Jean-Claude Gautier
Regine Bellamy
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO976125D0 publication Critical patent/NO976125D0/no
Publication of NO976125L publication Critical patent/NO976125L/no
Publication of NO317061B1 publication Critical patent/NO317061B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19976125A 1995-06-30 1997-12-29 Farmasoytisk preparat for parenteral administrering omfattende amiodaron eller et farmasoytisk akseptabelt salt derav NO317061B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507939A FR2735978B1 (fr) 1995-06-30 1995-06-30 Composition pharmaceutique d'amiodarone pour administration parenterale
PCT/FR1996/001010 WO1997002031A1 (fr) 1995-06-30 1996-06-28 Composition pharmaceutique d'amiodarone pour administration parenterale

Publications (3)

Publication Number Publication Date
NO976125D0 true NO976125D0 (no) 1997-12-29
NO976125L NO976125L (no) 1998-02-26
NO317061B1 NO317061B1 (no) 2004-08-02

Family

ID=9480596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19976125A NO317061B1 (no) 1995-06-30 1997-12-29 Farmasoytisk preparat for parenteral administrering omfattende amiodaron eller et farmasoytisk akseptabelt salt derav

Country Status (14)

Country Link
US (1) US6143778A (no)
EP (1) EP0835105B1 (no)
JP (1) JP3137987B2 (no)
AT (1) ATE213940T1 (no)
AU (1) AU6462596A (no)
BR (1) BR9609666A (no)
CA (1) CA2222304C (no)
DE (1) DE69619673T2 (no)
ES (1) ES2174083T3 (no)
FR (1) FR2735978B1 (no)
MX (1) MX9710206A (no)
NO (1) NO317061B1 (no)
WO (1) WO1997002031A1 (no)
ZA (1) ZA965525B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861539B1 (en) 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US7339078B2 (en) * 1995-03-10 2008-03-04 G.D. Searle Llc Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
FR2764800B1 (fr) 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
US6479541B1 (en) 2000-03-30 2002-11-12 Baxter International Amiodarone-containing parenteral administration
US6646195B1 (en) * 2000-04-12 2003-11-11 Microsoft Corporation Kernel-mode audio processing modules
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
RU2003131686A (ru) * 2001-03-29 2005-01-27 Бакстер Интернэшнл Инк. (Us) Предварительно смешанный раствор амиодарона для парентерального введения и способ его получения
US20020143051A1 (en) 2001-03-29 2002-10-03 Doty Mark J. Premixed amiodarone parenteral solution and method for making the same
CA2451839C (en) * 2001-06-22 2013-08-06 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions comprising peptides and permeation enhancers
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
CN1558755A (zh) 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
US6869939B2 (en) * 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
EP1653931A2 (en) * 2003-07-17 2006-05-10 Banner Pharmacaps, Inc. Controlled release preparations
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
US7754099B2 (en) 2004-04-26 2010-07-13 Mitsubishi Materials Corporation Reducing water purification material, method for producing reducing water purification material, method for treating wastewater, and wastewater treatment apparatus
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
KR101724166B1 (ko) * 2009-02-16 2017-04-18 주식회사 쿠라레 여과 유닛 및 이것을 구비한 밸러스트수 제조 장치
EP2335686A1 (en) 2009-12-21 2011-06-22 LEK Pharmaceuticals d.d. An aqueous intravenous nanosuspension with reduced adverse effects
CN103079559A (zh) 2010-06-11 2013-05-01 巴克斯特国际公司 包含胺碘酮及其盐的制剂及其制造和使用方法
JP6913458B2 (ja) * 2014-05-28 2021-08-04 武田薬品工業株式会社 抗菌水
WO2018175271A1 (en) * 2017-03-24 2018-09-27 Merck Sharp & Dohme Corp. Formulation for parenteral administration
US20220016070A1 (en) * 2020-07-17 2022-01-20 Good Health, Llc Premixed, ready to use pharmaceutical compositions of amiodarone
CN112472668B (zh) * 2020-10-29 2023-02-28 太阳升(亳州)生物医药科技有限公司 用于制备盐酸胺碘酮注射液的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234949A (en) * 1992-04-01 1993-08-10 Academic Pharmaceuticals, Inc. Parenteral solutions containing amiodarone in acetate buffer solution

Also Published As

Publication number Publication date
MX9710206A (es) 1998-03-31
EP0835105A1 (fr) 1998-04-15
WO1997002031A1 (fr) 1997-01-23
ZA965525B (en) 1997-12-29
US6143778A (en) 2000-11-07
DE69619673D1 (de) 2002-04-11
ATE213940T1 (de) 2002-03-15
BR9609666A (pt) 1999-05-25
JPH10510297A (ja) 1998-10-06
ES2174083T3 (es) 2002-11-01
AU6462596A (en) 1997-02-05
CA2222304C (fr) 2002-09-17
NO317061B1 (no) 2004-08-02
EP0835105B1 (fr) 2002-03-06
DE69619673T2 (de) 2002-11-14
CA2222304A1 (fr) 1997-01-23
NO976125L (no) 1998-02-26
JP3137987B2 (ja) 2001-02-26
FR2735978A1 (fr) 1997-01-03
FR2735978B1 (fr) 1997-09-19

Similar Documents

Publication Publication Date Title
NO976125D0 (no) Farmasöytisk amiodaronblanding for parenteral levering
EG20540A (en) New emulsion formulation
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
DE69919533D1 (de) Proteinhaltige arzneimittel
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
BR0209155A (pt) Tablete farmacêutico tendo um teor de api elevado
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION
ES2197781A1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
ATE162401T1 (de) Antivitale zusammensetzungen
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees